- In September 2024, GE HealthCare unveiled the upgraded Venue ultrasound systems, introducing the Venue Sprint, a groundbreaking solution in point-of-care ultrasound (POCUS). This device emphasizes portability while incorporating the user-friendly Venue software alongside AI-driven features for superior imaging quality. Additionally, it boasts wireless probe capabilities that work seamlessly with Vscan Air handheld ultrasound systems
- In August 2022, Echonous formed a partnership with Samsung to advance ultrasound imaging by leveraging AI-guided technology. This collaboration focuses on improving both the usability and accuracy of ultrasound procedures, thereby making them more accessible to healthcare providers. By incorporating artificial intelligence into their systems, the partnership aims to empower clinicians to deliver more accurate diagnostics and enhance overall patient care, aligning with the growing trend of integrating AI in medical imaging
- In April 2022, GE HealthCare and Elekta entered into a global commercial collaboration agreement focused on radiation oncology. This partnership aims to provide hospitals with a comprehensive solution that integrates imaging and treatment for cancer patients in need of radiation therapy. By combining their expertise, the two companies seek to enhance the quality of care and streamline processes for oncology services
- In March 2021, GE Healthcare, a leader in medical technology and digital solutions, introduced the Vscan Air, a wireless compact ultrasound device. This innovative tool offers exceptional image quality along with the ability to perform whole-body scans. The Vscan Air aims to enhance diagnostic capabilities and improve patient care through its portability and advanced imaging technology
- In October 2020, Clarius Mobile Health reported a growing acceptance of its Clarius L7 H.D. handheld ultrasound scanner among pain management specialists globally. This device provides high-quality ultrasound imaging of subcutaneous anatomy, facilitating more accurate and reliable placement of pain medication. The increasing adoption highlights the scanner's effectiveness in enhancing procedural precision and patient outcomes
Frequently Asked Questions
The market is segmented based on Segmentation, By Device Type (Handheld Ultrasound Device and Mobile Ultrasound Device), Application (Cardiovascular, Obstetrics and Gynecology, Gastric, Musculoskeletal, and Others), End Users (Hospitals, Diagnostic Centers, Ambulatory Care Centers, and Others) – Industry Trends and Forecast to 2031
.
The Global Portable Ultrasound Market size was valued at USD 4.72 USD Billion in 2023.
The Global Portable Ultrasound Market is projected to grow at a CAGR of 7.12% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
